Award

Delivery Order #SPE2DR26FCEU2

Delivery Order Awarded to DMS Pharmaceutical Group for Critical Medication Supply

Buyer

Defense Logistics Agency

Award Amount

$6.35

Ceiling

$6.35

Awarded

February 12, 2026

Period of Performance

Feb 12, 2026 – Feb 13, 2026

Identifier

SPE2DR26FCEU2

NAICS

325411

This delivery order contract, under the broader indefinite-delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., focuses on the procurement of a specific pharmaceutical product, ROBRAFEN DM 200-20 MG/20 ML LIQ 118ML. DMS Pharmaceutical Group, a company specializing in pharmaceuticals and healthcare solutions, is tasked with supplying this essential medication to support federal healthcare programs. The contract serves to ensure the agency's continued access to critical medications, contributing significantly to the maintenance of public health. The scope of work involves the timely delivery of this specified pharmaceutical product to a designated location in Park Ridge, Illinois, within a very short timeframe spanning just two days. This award follows a multi-year IDV contract that establishes a longer-term partnership facilitating such delivery orders. The contract was awarded through the existing IDV vehicle, indicating a streamlined procurement process likely under competitive terms consistent with federal purchasing regulations.

Description

4570851312!ROBAFEN DM 200-20 MG/20 ML LIQ 118ML

View original record